The University of Chicago Header Logo

Russell Szmulewitz

Concepts (319)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms, Castration-Resistant
37
2026
121
8.660
Why?
Phenylthiohydantoin
25
2026
58
4.070
Why?
Prostatic Neoplasms
38
2026
1846
3.830
Why?
Benzamides
25
2026
260
3.400
Why?
Nitriles
25
2026
172
3.070
Why?
Androstenes
14
2024
42
2.670
Why?
Receptors, Glucocorticoid
7
2024
145
2.250
Why?
Androgen Antagonists
18
2026
157
1.960
Why?
Receptors, Androgen
14
2024
126
1.900
Why?
Antineoplastic Combined Chemotherapy Protocols
15
2026
2666
1.590
Why?
Neoplasm Metastasis
25
2026
1102
1.330
Why?
Neoplastic Cells, Circulating
6
2024
78
1.140
Why?
Antineoplastic Agents
11
2023
2386
1.040
Why?
Male
77
2026
47475
0.890
Why?
Androgen Receptor Antagonists
6
2024
21
0.880
Why?
Prostate-Specific Antigen
10
2026
356
0.790
Why?
Food-Drug Interactions
2
2014
19
0.780
Why?
Sulfonamides
5
2019
352
0.760
Why?
Aged, 80 and over
29
2026
7461
0.700
Why?
Protein Kinase Inhibitors
3
2018
642
0.670
Why?
Aged
46
2026
21986
0.660
Why?
Humans
84
2026
98799
0.650
Why?
Testosterone
4
2021
266
0.610
Why?
Orchiectomy
4
2018
63
0.570
Why?
Antineoplastic Agents, Immunological
2
2019
238
0.560
Why?
Quality of Life
6
2024
1904
0.560
Why?
Middle Aged
41
2026
29642
0.560
Why?
Prospective Studies
14
2025
4837
0.550
Why?
Urinary Bladder Neoplasms
2
2024
403
0.550
Why?
Ascites
1
2018
55
0.530
Why?
Pyrimidines
5
2019
416
0.530
Why?
Food
1
2018
93
0.520
Why?
Gene Expression Regulation, Neoplastic
6
2022
1400
0.510
Why?
Protein-Tyrosine Kinases
2
2023
305
0.510
Why?
Small Molecule Libraries
1
2017
74
0.480
Why?
Glutamate Carboxypeptidase II
2
2026
7
0.480
Why?
Programmed Cell Death 1 Receptor
1
2018
201
0.480
Why?
Prednisone
5
2026
252
0.470
Why?
SOXB1 Transcription Factors
3
2023
30
0.460
Why?
Cell Line, Tumor
10
2024
2913
0.460
Why?
Treatment Outcome
20
2026
9806
0.420
Why?
Drug Resistance, Neoplasm
3
2016
671
0.410
Why?
Disease Progression
7
2020
1621
0.410
Why?
Neoplasms
7
2025
3382
0.410
Why?
Immediate-Early Proteins
2
2014
160
0.400
Why?
Patient Safety
4
2019
237
0.400
Why?
Carcinoma, Small Cell
1
2014
116
0.400
Why?
MAP Kinase Kinase 4
2
2011
61
0.400
Why?
Dietary Fats
1
2014
135
0.390
Why?
Food Labeling
1
2012
7
0.380
Why?
Indoles
1
2014
340
0.350
Why?
Gonadotropin-Releasing Hormone
2
2024
100
0.350
Why?
Antibodies, Monoclonal, Humanized
1
2018
1105
0.340
Why?
Kidney Neoplasms
3
2025
556
0.330
Why?
Cell Cycle Checkpoints
1
2011
68
0.330
Why?
Melanoma
1
2014
523
0.300
Why?
Antigens, Surface
2
2026
100
0.290
Why?
Mice, Nude
4
2017
829
0.290
Why?
Radioisotopes
2
2026
42
0.290
Why?
Cell Survival
3
2017
1018
0.290
Why?
Signal Transduction
9
2024
3642
0.290
Why?
Mifepristone
2
2022
59
0.270
Why?
Carcinoma, Renal Cell
2
2025
384
0.270
Why?
Hormones
3
2022
138
0.260
Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2024
90
0.250
Why?
Heterocyclic Compounds, 1-Ring
1
2026
1
0.240
Why?
Research Design
2
2026
652
0.240
Why?
Lutetium
1
2026
4
0.240
Why?
Dipeptides
1
2026
41
0.240
Why?
Iodine Radioisotopes
1
2026
145
0.230
Why?
Abiraterone Acetate
3
2026
14
0.230
Why?
Breast Neoplasms
2
2021
3303
0.230
Why?
Biomarkers, Tumor
6
2024
1786
0.220
Why?
Homeodomain Proteins
3
2024
568
0.220
Why?
Androgens
3
2023
164
0.210
Why?
Patient Portals
1
2025
36
0.210
Why?
Neutropenia
2
2023
211
0.210
Why?
Combined Modality Therapy
6
2026
1754
0.210
Why?
5-alpha Reductase Inhibitors
1
2024
12
0.210
Why?
Phthalazines
1
2024
60
0.200
Why?
Nuclear Medicine
1
2023
12
0.200
Why?
CDC2 Protein Kinase
1
2023
46
0.190
Why?
Radium
1
2023
7
0.190
Why?
Adenocarcinoma
2
2020
1215
0.190
Why?
Piperazines
1
2024
308
0.180
Why?
Capecitabine
2
2024
103
0.180
Why?
Receptors, Cytoplasmic and Nuclear
1
2023
127
0.180
Why?
Disease-Free Survival
4
2023
1196
0.180
Why?
Clinical Trials as Topic
2
2026
1128
0.170
Why?
Neoplasms, Second Primary
1
2024
244
0.170
Why?
Dehydroepiandrosterone
2
2020
47
0.170
Why?
Urinary Bladder
1
2024
263
0.170
Why?
Antineoplastic Agents, Hormonal
3
2024
161
0.170
Why?
Medical Oncology
1
2025
426
0.170
Why?
Prostatectomy
2
2026
491
0.170
Why?
Frailty
1
2023
106
0.170
Why?
Pharmacogenetics
1
2025
474
0.170
Why?
Chromosomal Instability
1
2021
22
0.170
Why?
Cell Proliferation
4
2017
1801
0.170
Why?
Radiosurgery
1
2025
352
0.170
Why?
Castration
2
2012
32
0.170
Why?
Cell Cycle Proteins
1
2023
420
0.160
Why?
Steroid 17-alpha-Hydroxylase
1
2020
16
0.160
Why?
Dose-Response Relationship, Drug
3
2019
1949
0.160
Why?
Health Expenditures
1
2021
118
0.160
Why?
Glucocorticoids
2
2024
371
0.160
Why?
DNA Methylation
1
2025
735
0.150
Why?
Adult
15
2025
29698
0.150
Why?
Double-Blind Method
5
2025
1793
0.150
Why?
Dietary Supplements
1
2021
152
0.150
Why?
Organic Chemicals
1
2019
38
0.150
Why?
Pain
1
2022
417
0.150
Why?
Boronic Acids
1
2019
56
0.150
Why?
Oxidoreductases
1
2019
112
0.150
Why?
Taxoids
2
2016
127
0.140
Why?
Animals
8
2024
29045
0.140
Why?
Pyridones
1
2019
74
0.140
Why?
Aurora Kinase A
1
2018
15
0.140
Why?
Pyrrolidinones
1
2018
15
0.140
Why?
Azepines
1
2018
29
0.140
Why?
N-Myc Proto-Oncogene Protein
1
2018
41
0.140
Why?
Immunoconjugates
1
2019
140
0.140
Why?
Myeloid Ecotropic Viral Integration Site 1 Protein
1
2018
20
0.140
Why?
Singapore
1
2018
14
0.140
Why?
Carcinoma, Neuroendocrine
1
2018
48
0.140
Why?
Bone Neoplasms
1
2020
316
0.140
Why?
Recurrence
2
2019
1274
0.130
Why?
United States
6
2020
8387
0.130
Why?
Indazoles
4
2023
65
0.130
Why?
Quinolines
1
2018
97
0.130
Why?
Urologic Neoplasms
1
2018
82
0.130
Why?
Fasting
1
2018
166
0.130
Why?
Enzyme Inhibitors
1
2020
641
0.130
Why?
Positron Emission Tomography Computed Tomography
1
2018
108
0.130
Why?
Female
12
2025
51997
0.130
Why?
Antimetabolites, Antineoplastic
1
2018
246
0.130
Why?
Patient Reported Outcome Measures
1
2020
337
0.130
Why?
Feasibility Studies
2
2021
818
0.120
Why?
Mice
6
2024
12762
0.120
Why?
Proto-Oncogene Proteins c-met
1
2018
199
0.120
Why?
Neoadjuvant Therapy
1
2020
477
0.120
Why?
Quinolones
1
2016
59
0.120
Why?
Survival Rate
4
2026
2057
0.120
Why?
Tissue Array Analysis
2
2018
135
0.120
Why?
Chemoradiotherapy
1
2018
337
0.120
Why?
Prostate
4
2025
434
0.110
Why?
Xenograft Model Antitumor Assays
2
2016
559
0.110
Why?
Benzodioxoles
1
2015
15
0.110
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2014
889
0.110
Why?
Steroid Synthesis Inhibitors
1
2014
1
0.110
Why?
Neoplasm Recurrence, Local
3
2025
1538
0.110
Why?
Maximum Tolerated Dose
3
2019
265
0.110
Why?
Angiogenesis Inhibitors
1
2016
281
0.100
Why?
Quinazolines
1
2015
222
0.100
Why?
Metribolone
1
2014
6
0.100
Why?
Estrogen Receptor alpha
1
2015
159
0.100
Why?
Benzoates
1
2014
34
0.100
Why?
Proteins
1
2019
804
0.100
Why?
Life Expectancy
1
2014
93
0.100
Why?
Immunoblotting
1
2014
273
0.100
Why?
CD8-Positive T-Lymphocytes
1
2018
701
0.100
Why?
Prognosis
3
2018
4139
0.100
Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2014
112
0.100
Why?
Population Surveillance
1
2014
218
0.100
Why?
Flow Cytometry
1
2014
722
0.090
Why?
RNA Interference
1
2014
388
0.090
Why?
Academic Medical Centers
1
2015
416
0.090
Why?
Microscopy, Fluorescence
1
2014
435
0.090
Why?
Adrenal Cortex Hormones
1
2014
308
0.090
Why?
Hospitalization
1
2018
993
0.090
Why?
Transcription, Genetic
1
2017
1136
0.090
Why?
Transcription Factors
2
2018
1724
0.090
Why?
Dexamethasone
1
2014
318
0.090
Why?
Precision Medicine
3
2025
512
0.090
Why?
Risk Assessment
3
2026
2604
0.090
Why?
Immunotherapy
1
2018
831
0.090
Why?
HEK293 Cells
1
2014
724
0.090
Why?
Neoplasm Staging
3
2026
2087
0.080
Why?
Follow-Up Studies
3
2025
4049
0.080
Why?
Neoplasms, Hormone-Dependent
1
2011
35
0.080
Why?
G1 Phase
1
2011
66
0.080
Why?
Decision Making
2
2014
691
0.080
Why?
Survival Analysis
1
2014
1530
0.080
Why?
Genes, Tumor Suppressor
1
2011
156
0.080
Why?
Clinical Trials, Phase II as Topic
2
2025
168
0.080
Why?
Tumor Burden
1
2011
330
0.080
Why?
Chicago
3
2025
1520
0.070
Why?
Repressor Proteins
1
2013
450
0.070
Why?
Nausea
2
2019
95
0.070
Why?
Predictive Value of Tests
3
2021
1792
0.070
Why?
Administration, Cutaneous
1
2009
66
0.070
Why?
Tissue Distribution
2
2019
290
0.070
Why?
Time Factors
3
2026
5586
0.070
Why?
Muscle Strength
1
2009
53
0.070
Why?
Early Detection of Cancer
1
2014
563
0.070
Why?
Geriatric Assessment
2
2023
193
0.060
Why?
Immunohistochemistry
1
2011
1818
0.060
Why?
Thiohydantoins
1
2026
4
0.060
Why?
Gene Expression Regulation
1
2014
2023
0.060
Why?
High-Intensity Focused Ultrasound Ablation
1
2025
54
0.050
Why?
Rats
1
2011
4079
0.050
Why?
Age Factors
2
2023
1976
0.050
Why?
Neoplasm, Residual
1
2026
205
0.050
Why?
CpG Islands
1
2025
177
0.050
Why?
Ataxia Telangiectasia Mutated Proteins
1
2024
65
0.050
Why?
Leuprolide
1
2024
34
0.050
Why?
Magnetic Resonance Imaging
1
2016
3622
0.050
Why?
Pharmacogenomic Testing
1
2025
119
0.050
Why?
Comorbidity
2
2021
1037
0.050
Why?
Reproducibility of Results
2
2021
2799
0.050
Why?
Scandium
1
2023
4
0.050
Why?
DNA, Complementary
1
2024
380
0.050
Why?
BRCA2 Protein
1
2024
178
0.050
Why?
Cohort Studies
2
2021
3242
0.050
Why?
RNA, Messenger
2
2024
2076
0.050
Why?
BRCA1 Protein
1
2024
222
0.050
Why?
Patient Participation
1
2025
251
0.050
Why?
Retrospective Studies
3
2024
11104
0.050
Why?
Cystectomy
1
2024
125
0.050
Why?
DNA Repair
1
2024
363
0.050
Why?
Early Termination of Clinical Trials
2
2012
16
0.050
Why?
Pilot Projects
1
2025
978
0.040
Why?
Febrile Neutropenia
1
2022
16
0.040
Why?
Cyclin-Dependent Kinase 4
1
2022
37
0.040
Why?
Neoplasm Invasiveness
1
2024
583
0.040
Why?
Aminopyridines
1
2022
54
0.040
Why?
Thyrotoxicosis
1
2001
18
0.040
Why?
Cisplatin
1
2024
578
0.040
Why?
Purines
1
2022
97
0.040
Why?
Tissue Extracts
1
2021
24
0.040
Why?
Cellular Reprogramming
1
2022
56
0.040
Why?
Piperidines
1
2023
177
0.040
Why?
Interleukin-7
1
2021
48
0.040
Why?
Keratins
1
2021
63
0.040
Why?
Leukocyte Common Antigens
1
2021
50
0.040
Why?
Neurosecretory Systems
1
2021
36
0.040
Why?
Cell Count
1
2021
195
0.040
Why?
Glycolysis
1
2022
198
0.040
Why?
Asymptomatic Diseases
1
2021
48
0.040
Why?
Thyroid Hormone Resistance Syndrome
1
2001
117
0.040
Why?
Prescription Drugs
1
2021
42
0.040
Why?
Drug Interactions
1
2021
240
0.040
Why?
Epigenesis, Genetic
1
2025
595
0.040
Why?
Cross-Over Studies
1
2021
394
0.040
Why?
Neutrophils
1
2021
346
0.040
Why?
RNA
1
2024
596
0.040
Why?
Recombinant Proteins
1
2021
994
0.040
Why?
Lymphocytes
1
2021
461
0.040
Why?
Steroids
1
2020
168
0.040
Why?
Vomiting
1
2019
109
0.040
Why?
Tumor Suppressor Proteins
2
2013
318
0.030
Why?
Clinical Decision-Making
1
2021
306
0.030
Why?
Chemotherapy, Adjuvant
1
2020
527
0.030
Why?
Pregnancy Complications
1
2001
371
0.030
Why?
Lymphocyte Activation
1
2021
825
0.030
Why?
Lung Neoplasms
1
2011
2474
0.030
Why?
Bradycardia
1
2018
52
0.030
Why?
Protein Isoforms
1
2019
305
0.030
Why?
Drug Administration Schedule
1
2019
837
0.030
Why?
Kinetics
1
2020
1478
0.030
Why?
Mitochondria
1
2022
653
0.030
Why?
Antigens, Neoplasm
1
2019
366
0.030
Why?
Kaplan-Meier Estimate
1
2019
909
0.030
Why?
Prevalence
1
2021
1396
0.030
Why?
Remission Induction
1
2018
764
0.030
Why?
Risk Factors
2
2020
6295
0.030
Why?
Transcriptome
1
2021
828
0.030
Why?
Administration, Oral
1
2016
677
0.030
Why?
Nanog Homeobox Protein
1
2014
8
0.030
Why?
Ketoconazole
1
2014
23
0.030
Why?
Neoplasm Proteins
1
2018
553
0.030
Why?
Retreatment
1
2014
106
0.030
Why?
Polymorphism, Restriction Fragment Length
1
2014
145
0.030
Why?
Immunoprecipitation
1
2014
140
0.030
Why?
Protein Binding
1
2018
1564
0.030
Why?
Phenotype
1
2021
2673
0.030
Why?
Antibodies, Monoclonal
1
2019
1422
0.020
Why?
Cause of Death
1
2014
279
0.020
Why?
Mortality
1
2014
160
0.020
Why?
Blotting, Western
1
2014
779
0.020
Why?
Activities of Daily Living
1
2014
214
0.020
Why?
Mutation
1
2024
4443
0.020
Why?
Kallikreins
1
2012
47
0.020
Why?
Embryonic Stem Cells
1
2013
87
0.020
Why?
Surveys and Questionnaires
1
2021
3058
0.020
Why?
Multicenter Studies as Topic
1
2012
195
0.020
Why?
United States Department of Defense
1
2011
4
0.020
Why?
Up-Regulation
1
2014
742
0.020
Why?
Proportional Hazards Models
1
2014
925
0.020
Why?
Health Status
1
2014
388
0.020
Why?
Contrast Media
1
2016
1014
0.020
Why?
Diarrhea
1
2011
180
0.020
Why?
Universities
1
2011
166
0.020
Why?
Fatigue
1
2011
187
0.020
Why?
Logistic Models
1
2014
1276
0.020
Why?
Patient Compliance
1
2011
247
0.020
Why?
Body Mass Index
1
2014
869
0.020
Why?
Smoking
1
2014
676
0.020
Why?
Databases, Factual
1
2014
1102
0.020
Why?
Epithelial Cells
1
2013
710
0.020
Why?
Patient Education as Topic
1
2012
419
0.020
Why?
Patient Selection
1
2012
725
0.020
Why?
Mass Screening
1
2014
753
0.020
Why?
Randomized Controlled Trials as Topic
1
2012
995
0.020
Why?
p38 Mitogen-Activated Protein Kinases
1
2008
123
0.020
Why?
Cross-Sectional Studies
1
2014
2077
0.020
Why?
Health Knowledge, Attitudes, Practice
1
2012
608
0.020
Why?
Cell Death
1
2008
258
0.020
Why?
Cell Division
1
2008
690
0.020
Why?
Young Adult
1
2019
7598
0.020
Why?
Cell Cycle
1
2008
519
0.010
Why?
Adolescent
1
2019
10168
0.010
Why?
Homeostasis
1
2008
474
0.010
Why?
Chorionic Gonadotropin
1
2001
69
0.010
Why?
Thyroid Function Tests
1
2001
125
0.010
Why?
Pedigree
1
2001
988
0.010
Why?
Thyroid Hormones
1
2001
358
0.010
Why?
Ultrasonography
1
2001
722
0.010
Why?
Pregnancy
1
2001
3286
0.010
Why?
Szmulewitz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (319)
Explore
_
Co-Authors (46)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_